NCT06001788 2025-12-03Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid LeukemiaKura Oncology, Inc.Phase 1 Recruiting171 enrolled
NCT03779854 2025-10-15Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell TransplantFred Hutchinson Cancer CenterPhase 2 Recruiting68 enrolled
NCT05805605 2025-07-01Allo HSCT Using RIC and PTCy for Hematological DiseasesMasonic Cancer Center, University of MinnesotaPhase 2 Recruiting56 enrolled